Loading clinical trials...
Loading clinical trials...
This study evaluates the therapeutic effects of constraint-induced movement therapy on infants and children with hemiplegic cerebral palsy. Half of the participants will receive CIMT (constraint-induced movement therapy) and others will not.
This study evaluates the therapeutic effects of constraint-induced movement therapy on infants and children with hemiplegic cerebral palsy. Half of the participants will receive CIMT (constraint-induced movement therapy) and others will not. Participants will be randomly assigned to either CIMT group or control group. Children of the CIMT group will wear forearm splint 24 hours for 3 weeks to inhibit use of the unaffected arm.
Age
0 - 3 years
Sex
ALL
Healthy Volunteers
No
Samsung Medical Center
Seoul, South Korea
Start Date
September 14, 2015
Primary Completion Date
September 28, 2019
Completion Date
September 28, 2019
Last Updated
July 28, 2020
32
ACTUAL participants
Constraint-induced movement therapy
OTHER
Lead Sponsor
Samsung Medical Center
NCT06753812
NCT07247812
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06560281